BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · Real-Time Price · USD
2.140
+0.050 (2.39%)
Nov 28, 2025, 4:00 PM EST - Market closed
BeyondSpring Market Cap
BeyondSpring has a market cap or net worth of $88 million as of November 28, 2025. Its market cap has increased by 10.28% in one year.
Market Cap
88.00M
Enterprise Value
74.96M
1-Year Change
10.28%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since March 9, 2017, BeyondSpring's market cap has decreased from $362.10M to $88.00M, a decrease of -75.70%. That is a compound annual growth rate of -14.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 84.30M | 28.31% |
| Dec 31, 2024 | 65.70M | 87.18% |
| Dec 29, 2023 | 35.10M | -52.05% |
| Dec 30, 2022 | 73.20M | -58.71% |
| Dec 31, 2021 | 177.30M | -52.38% |
| Dec 31, 2020 | 372.30M | -7.48% |
| Dec 31, 2019 | 402.40M | -4.76% |
| Dec 31, 2018 | 422.50M | -32.59% |
| Dec 29, 2017 | 626.80M | 73.10% |
| Mar 9, 2017 | 362.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |